Chronic Diseases Fueling Growth In Drug Delivery Devices Market: Core Growth Enabler in the Drug Delivery Devices Market, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Drug Delivery Devices Market Size By 2025?
In the past few years, the market size of drug delivery devices has seen a substantial increase. The market is projected to expand from $91.03 billion in 2024 to $96.73 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Various factors that have contributed to the growth during the historic period include an escalating elderly population, increase in the count of healthcare facilities, economic expansion in developing markets, and a rise in healthcare spending.

How Big Is the Drug Delivery Devices Market Size Expected to Grow by 2029?
Anticipated substantial progress in the next few years is expected to significantly increase the market size of drug delivery devices, which is forecasted to reach $124.82 billion by 2029, scaling at a compound annual growth rate (CAGR) of 6.6%. The surge in growth during the forecast period can be ascribed to higher prevalence of chronic diseases, escalated demand from injectables, heightened need for drug delivery devices, and the sudden advent of serious infections. Leading trends predicted for this period involve investment in microneedle drug technology for drug delivery, research and development into self-injectable drug delivery devices, a focus on mergers and acquisitions, and funding wearable drug delivery devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Which Key Market Drivers Powering Drug Delivery Devices Market Expansion and Growth?
The escalating occurrence of chronic diseases such as heart diseases, diabetes, cancer, among others, is anticipated to fuel the growth of the drug delivery devices market. For example, the National Library of Medicine, a medical library in the United States supervised by the federal government, reported in January 2023 that the population of individuals over the age of 50 with at least one chronic malady in the United States is projected to surge by 99.5%. This increase would elevate the count from 71.522 million in 2020 to 142.66 million by 2050. There are numerous avenues for administering medical drugs, and the invention of novel drug delivery systems is pivotal in the pharmaceutical sector. Global research and development in drug delivery is on the rise due to the escalating frequency of these diseases. A large number of pharmaceutical firms are focusing on several drug delivery technologies to create superior benefits and improved results for their marketed products. Consequently, the escalating occurrence of chronic diseases is leading to a boosting usage of therapeutic drugs and therapies, and this element is expected to be a driver for the expansion of the drug delivery devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Drug Delivery Devices Market?
Leading pharmaceutical corporations in the drug delivery device market have steadily concentrated on the manufacture of unique innovations, such as self-administered medication dispensers known as autoinjectors, which come fully integrated with modern connectivity features. This is in an effort to establish a dominant position within the industry. Notably, Jabil Healthcare, a U.S. company that offers healthcare manufacturing services, launched a novel drug delivery instrument known as Qfinity autoinjector platform in May 2022. This device stands out due to its reusable nature and modular design, providing an affordable and sustainable option for self-injecting drugs beneath the skin. It offers a competitive edge against current market offerings and caters to a diverse range of drug volumes and viscosities. It also boasts a patient-friendly design and can significantly reduce costs per injection up to a striking 65%, in contrast to popular disposable autoinjectors. The well-engineered Qfinity device can withstand over 100 injections using 1 mL or 2.25 mL prefilled disposable cassettes. Furthermore, the device minimizes component and material usage, indicating a 65% drop in injection costs, a 60% smaller carbon footprint, a 50% decrease in manufacturing space and a massive 70% decrease in capital expenditure (CAPEX).

What Are the Emerging Segments in the Drug Delivery Devices Market?
The drug delivery devices market covered in this report is segmented -

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:
1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

Who Are the Global Leaders in the Drug Delivery Devices Market?
Major companies operating in the drug delivery devices market include Becton, dic*kinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

Which are the Top Profitable Regional Markets for the Drug Delivery Devices Industry?
North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.